Review on Recent Advance in Veterinary Vaccine

Tesfa Mossie

doi:doi:10.11648/j.avs.20221005.14

| Peer-Reviewed

Review on Recent Advance in Veterinary Vaccine

Tesfa Mossie

Published in Animal and Veterinary Sciences (Volume 10, Issue 5)

Received: 5 September 2022 Accepted: 24 October 2022 Published: 29 October 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The licensed veterinary vaccine is the most cost-effective strategy for the prevention, control, and eradication of a wide variety of new and re-emerging infectious diseases in both humans and animals. This in turn leads to improvements in animal welfare, decreased antibiotic residues in food chains, being able to reduce the human susceptibility to zoonotic diseases and decreasing the production cost of food animals. There has also been a great improvement in the country's economy. Killed or live modified viral and bacterial vaccines are conventional vaccines that have been used for many centuries in the routine vaccination of production animals, companion animals, and human beings. The limitations of conventional vaccines are alleviated by novel concepts of vaccine development. Numerous novel, safer, and more effective vaccinations have been created as a result of current advancements in molecular biology, immunology, microbiology, and genetics. The development of vaccinations that provide immunity to many diseases simultaneously is one of the innovative vaccine technological improvements enabled by genetic editing. Vaccines that are designed based on genetic engineering are DNA/RNA vaccine, live attenuated vaccine, live recombinant vaccine, polynucleotide vaccine, and marker vaccine. Since they provide several advantages over conventional vaccines, these vaccines are actively being investigated against a variety of livestock and human diseases. Easy production, amount of vaccine produced, safety, immunogenicity, multivalency in a single host, ease of administration, and improved stability made the advanced vaccine more appropriate than a conventional vaccine.

Published in	Animal and Veterinary Sciences (Volume 10, Issue 5)
DOI	10.11648/j.avs.20221005.14
Page(s)	148-154
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Vaccine, Advance Vaccine, Live Attenuated Vaccine, Killed Vaccine

References

[1]	Babiuk, L A. (2002). Review Vaccination : A Management tool in Veterinary Medicine. 188–201. https://doi.org/10.1053/tvjl.2001.0663
[2]	Babiuk, Lorne A, Lewis, J., Suradhat, S., Baca-estrada, M., Foldvari, M., & Babiuk, S. (1999). Polynucleotide vaccines: potential for inducing immunity in animals. 73, 131–140.
[3]	Dertzbaugh, M. T. (1998). Genetically engineered vaccines: An overview. Plasmid, 39 (2), 100–113. https://doi.org/10.1006/plas.1997.1329
[4]	Francis, M. J. (2020). Recent Advances in Vaccine Technologies.
[5]	Gadissa, L., and Yune, N. (2018). Update on Veterinary Viral Vaccines : A review open-access Journal of Veterinary Science and Research. 1–12.
[6]	Ganguly, S., Padhy, A., Para, P. A., Pandey, A. K., Praveen, P. K., Wakchaure, R., and Sahu, A. R. (2015). DIVA Vaccines: A Brief Review on its Novel Facets for the Eradication of Infections of Livestock and Poultry. 1 (3), 22–23.
[7]	Henderson, L. M. (2005). Overview of marker vaccine and differential diagnostic test technology. 33, 203–209.
[8]	Jorge, S., and Dellagostin, O. A. (2017). The development of veterinary vaccines : a review of traditional methods and modern biotechnology approaches. 6–13.
[9]	Lee, N., Lee, J., Park, S., Song, C., Choi, I., and Lee, J. (2012). Clinical experimental vaccine. A review of vaccine development and research for industry animals in Korea.
[10]	Liu, M. A. (2014). Vaccines and Vaccine Technologies. Vaccines and Vaccine Technologies.
[11]	Mcvey, S. (2010). Vaccines in Veterinary Medicine : A Brief Review of Vaccines in Veterinary Medicine : A Brief Review of History and Technology. Small Animal Practice, 40 (3), 381–392.
[12]	Meeusen, E. N. T., Walker, J., Peters, A., Pastoret, P., and Jungersen, G. (2007). Current Status of Veterinary Vaccines. Clinical Veterinary Journal, 20 (3), 489–510.
[13]	Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines a new era in vaccinology. Nature Reviews Drug Discovery, 17 (4), 261–279.
[14]	Ramadevi Nimmanapalli and Vikas Gupta. (2020). Vaccines the tugboat for prevention-based animal production.
[15]	Ruano, P., Delgado, L. L., Picco, S., Villegas, L., Tonelli, F., Merlo, M., Masuelli, M. (2016). We are intech open, the world’s leading publisher of Open Access books Built by scientists, for scientists TOP 1%. Intech, (tourism), 13.
[16]	Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., and Group, F. (2018). Annals of Medicine Understanding modern-day vaccines : what you need to know. Annals of Medicine, 110–120.
[17]	Zhang, C., Maruggi, G., Shan, H., and Li, J. (2019). Advances in mRNA vaccines for infectious diseases. Frontiers in Immunology, 10, 1–13.

Cite This Article

Plain Text BibTeX RIS

APA Style

Tesfa Mossie. (2022). Review on Recent Advance in Veterinary Vaccine. Animal and Veterinary Sciences, 10(5), 148-154. https://doi.org/10.11648/j.avs.20221005.14

Copy | Download

ACS Style

Tesfa Mossie. Review on Recent Advance in Veterinary Vaccine. Anim. Vet. Sci. 2022, 10(5), 148-154. doi: 10.11648/j.avs.20221005.14

Copy | Download

AMA Style

Tesfa Mossie. Review on Recent Advance in Veterinary Vaccine. Anim Vet Sci. 2022;10(5):148-154. doi: 10.11648/j.avs.20221005.14

Copy | Download

@article{10.11648/j.avs.20221005.14,
  author = {Tesfa Mossie},
  title = {Review on Recent Advance in Veterinary Vaccine},
  journal = {Animal and Veterinary Sciences},
  volume = {10},
  number = {5},
  pages = {148-154},
  doi = {10.11648/j.avs.20221005.14},
  url = {https://doi.org/10.11648/j.avs.20221005.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.avs.20221005.14},
  abstract = {The licensed veterinary vaccine is the most cost-effective strategy for the prevention, control, and eradication of a wide variety of new and re-emerging infectious diseases in both humans and animals. This in turn leads to improvements in animal welfare, decreased antibiotic residues in food chains, being able to reduce the human susceptibility to zoonotic diseases and decreasing the production cost of food animals. There has also been a great improvement in the country's economy. Killed or live modified viral and bacterial vaccines are conventional vaccines that have been used for many centuries in the routine vaccination of production animals, companion animals, and human beings. The limitations of conventional vaccines are alleviated by novel concepts of vaccine development. Numerous novel, safer, and more effective vaccinations have been created as a result of current advancements in molecular biology, immunology, microbiology, and genetics. The development of vaccinations that provide immunity to many diseases simultaneously is one of the innovative vaccine technological improvements enabled by genetic editing. Vaccines that are designed based on genetic engineering are DNA/RNA vaccine, live attenuated vaccine, live recombinant vaccine, polynucleotide vaccine, and marker vaccine. Since they provide several advantages over conventional vaccines, these vaccines are actively being investigated against a variety of livestock and human diseases. Easy production, amount of vaccine produced, safety, immunogenicity, multivalency in a single host, ease of administration, and improved stability made the advanced vaccine more appropriate than a conventional vaccine.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Review on Recent Advance in Veterinary Vaccine
AU  - Tesfa Mossie
Y1  - 2022/10/29
PY  - 2022
N1  - https://doi.org/10.11648/j.avs.20221005.14
DO  - 10.11648/j.avs.20221005.14
T2  - Animal and Veterinary Sciences
JF  - Animal and Veterinary Sciences
JO  - Animal and Veterinary Sciences
SP  - 148
EP  - 154
PB  - Science Publishing Group
SN  - 2328-5850
UR  - https://doi.org/10.11648/j.avs.20221005.14
AB  - The licensed veterinary vaccine is the most cost-effective strategy for the prevention, control, and eradication of a wide variety of new and re-emerging infectious diseases in both humans and animals. This in turn leads to improvements in animal welfare, decreased antibiotic residues in food chains, being able to reduce the human susceptibility to zoonotic diseases and decreasing the production cost of food animals. There has also been a great improvement in the country's economy. Killed or live modified viral and bacterial vaccines are conventional vaccines that have been used for many centuries in the routine vaccination of production animals, companion animals, and human beings. The limitations of conventional vaccines are alleviated by novel concepts of vaccine development. Numerous novel, safer, and more effective vaccinations have been created as a result of current advancements in molecular biology, immunology, microbiology, and genetics. The development of vaccinations that provide immunity to many diseases simultaneously is one of the innovative vaccine technological improvements enabled by genetic editing. Vaccines that are designed based on genetic engineering are DNA/RNA vaccine, live attenuated vaccine, live recombinant vaccine, polynucleotide vaccine, and marker vaccine. Since they provide several advantages over conventional vaccines, these vaccines are actively being investigated against a variety of livestock and human diseases. Easy production, amount of vaccine produced, safety, immunogenicity, multivalency in a single host, ease of administration, and improved stability made the advanced vaccine more appropriate than a conventional vaccine.
VL  - 10
IS  - 5
ER  -

Copy | Download

Author Information

Tesfa Mossie

Ethiopian Institute of Agriculture Research, Jimma, Ethiopia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Tesfa Mossie. (2022). Review on Recent Advance in Veterinary Vaccine. Animal and Veterinary Sciences, 10(5), 148-154. https://doi.org/10.11648/j.avs.20221005.14

Copy | Download

ACS Style

Tesfa Mossie. Review on Recent Advance in Veterinary Vaccine. Anim. Vet. Sci. 2022, 10(5), 148-154. doi: 10.11648/j.avs.20221005.14

Copy | Download

AMA Style

Tesfa Mossie. Review on Recent Advance in Veterinary Vaccine. Anim Vet Sci. 2022;10(5):148-154. doi: 10.11648/j.avs.20221005.14

Copy | Download

@article{10.11648/j.avs.20221005.14,
  author = {Tesfa Mossie},
  title = {Review on Recent Advance in Veterinary Vaccine},
  journal = {Animal and Veterinary Sciences},
  volume = {10},
  number = {5},
  pages = {148-154},
  doi = {10.11648/j.avs.20221005.14},
  url = {https://doi.org/10.11648/j.avs.20221005.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.avs.20221005.14},
  abstract = {The licensed veterinary vaccine is the most cost-effective strategy for the prevention, control, and eradication of a wide variety of new and re-emerging infectious diseases in both humans and animals. This in turn leads to improvements in animal welfare, decreased antibiotic residues in food chains, being able to reduce the human susceptibility to zoonotic diseases and decreasing the production cost of food animals. There has also been a great improvement in the country's economy. Killed or live modified viral and bacterial vaccines are conventional vaccines that have been used for many centuries in the routine vaccination of production animals, companion animals, and human beings. The limitations of conventional vaccines are alleviated by novel concepts of vaccine development. Numerous novel, safer, and more effective vaccinations have been created as a result of current advancements in molecular biology, immunology, microbiology, and genetics. The development of vaccinations that provide immunity to many diseases simultaneously is one of the innovative vaccine technological improvements enabled by genetic editing. Vaccines that are designed based on genetic engineering are DNA/RNA vaccine, live attenuated vaccine, live recombinant vaccine, polynucleotide vaccine, and marker vaccine. Since they provide several advantages over conventional vaccines, these vaccines are actively being investigated against a variety of livestock and human diseases. Easy production, amount of vaccine produced, safety, immunogenicity, multivalency in a single host, ease of administration, and improved stability made the advanced vaccine more appropriate than a conventional vaccine.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Review on Recent Advance in Veterinary Vaccine
AU  - Tesfa Mossie
Y1  - 2022/10/29
PY  - 2022
N1  - https://doi.org/10.11648/j.avs.20221005.14
DO  - 10.11648/j.avs.20221005.14
T2  - Animal and Veterinary Sciences
JF  - Animal and Veterinary Sciences
JO  - Animal and Veterinary Sciences
SP  - 148
EP  - 154
PB  - Science Publishing Group
SN  - 2328-5850
UR  - https://doi.org/10.11648/j.avs.20221005.14
AB  - The licensed veterinary vaccine is the most cost-effective strategy for the prevention, control, and eradication of a wide variety of new and re-emerging infectious diseases in both humans and animals. This in turn leads to improvements in animal welfare, decreased antibiotic residues in food chains, being able to reduce the human susceptibility to zoonotic diseases and decreasing the production cost of food animals. There has also been a great improvement in the country's economy. Killed or live modified viral and bacterial vaccines are conventional vaccines that have been used for many centuries in the routine vaccination of production animals, companion animals, and human beings. The limitations of conventional vaccines are alleviated by novel concepts of vaccine development. Numerous novel, safer, and more effective vaccinations have been created as a result of current advancements in molecular biology, immunology, microbiology, and genetics. The development of vaccinations that provide immunity to many diseases simultaneously is one of the innovative vaccine technological improvements enabled by genetic editing. Vaccines that are designed based on genetic engineering are DNA/RNA vaccine, live attenuated vaccine, live recombinant vaccine, polynucleotide vaccine, and marker vaccine. Since they provide several advantages over conventional vaccines, these vaccines are actively being investigated against a variety of livestock and human diseases. Easy production, amount of vaccine produced, safety, immunogenicity, multivalency in a single host, ease of administration, and improved stability made the advanced vaccine more appropriate than a conventional vaccine.
VL  - 10
IS  - 5
ER  -

Copy | Download